Bioequivalence Study for Acarbose/Metformin FDC

Clinical trial NCT04065581 · COMPLETED

Trial details

NCT number: NCT04065581
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2019-10-14
Primary completion: 2019-11-25
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.